Original challenge: How might we increase participation in clinical studies at the Study Unit ASC, so that the number of clinical studies in Region Stockholm can increase?
Challenge from: Stockholms Läns Sjukvårdsområde – Studieenheten ASC, Region Stockholm
Redefined challenge: In order to recruit more participants, how can we actively raise the level of awareness about the Study Unit (ASC), spread accessible information across potential participants and foster trust toward clinical trials?
Solution: Clinical heroes
Concept: Based on our research and concept development, we propose the ‘Clinical Heroes’ initiative as the ultimate integrated strategy for ASC to enhance clinical trial participation and engagement. Rather than relying on financial incentives, this programme focuses on redefining clinical trial participation as a meaningful act of social contribution. It aims to increase public awareness, trust, and willingness through marketing communication, outreach, and recognition. This strategy constitutes a low-cost, ethically sound, and scalable system that can be progressively implemented within the study unit.
Team: triALL
Hanna Jakobsson, Ella Boere, Mahisha Alring, Xiaojie Chen.

Report abstract

This project was given to us from Stockholms Läns Sjukvårdsområde (SLSO), specifically the Academic Specialist Center (ASC). The challenge provided by the ASC addresses the difficulties of how to increase participation in clinical studies at the study unit. SLSO is one of the largest healthcare providers within Region Stockholm, responsible for a wide range of services in both specialized and primary care.  

Through (street) interviews, questionnaires, prototyping, testing and digital research we gathered insights that shaped our new point of view. What proved to be important is awareness, accessible information and trust. With this knowledge we formulated the following POV: In order to recruit more participants, how can we actively raise the level of awareness about the Study Unit (ASC), spread accessible information across potential participants and foster trust toward clinical trials. Our gathered insights from the data collection resulted in our final concept ‘Clinical Heroes’.